3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
8
Glioblastoma
3
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Brain Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Sarcoma
1
Oligodendroglioma
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Muscle-invasive Urothelial Cancer of the Bladder
1
Mouth Neoplasms
1
Lymphoma, Follicular
1
Laryngeal Neoplasms
1
Glioma
1
Giant Cell Tumor of Bone
1
Ganglioneuroblastoma
1
Estrogen Receptor Positive Breast Cancer
1
Craniopharyngioma
1
Carcinoma
1
Astrocytoma
1
Alzheimer Disease
1
Interventions
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Biopsy
6
Nuclear Medicine Department, Hospital
5
Etoposide
5
Nivolumab
4
Bevacizumab
4
Radiation
3
Irinotecan
3
Automobiles
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
abemaciclib
2
Watchful Waiting
2
Radiotherapy
2
ONC206
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
Transurethral Resection of Bladder
×
1 year
×
Clear all
No trials found.